Citadel Advisors’s Acadia Healthcare ACHC Stock Holding History

Citadel Advisors’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$968K	Sell	41,400 -4,600	-10%	-$83.3K	﹤0.01%	7726
2025 Q4	$653K	Sell	46,000 -19,400	-30%	-$367K	﹤0.01%	8370
2025 Q3	$1.62M	Buy	65,400 +19,100	+41%	+$426K	﹤0.01%	6499
2025 Q2	$1.05M	Sell	46,300 -78,800	-63%	-$1.87M	﹤0.01%	6975
2025 Q1	$3.79M	Buy	125,100 +75,500	+152%	+$2.88M	﹤0.01%	4344
2024 Q4	$1.97M	Buy	49,600 +5,200	+12%	+$235K	﹤0.01%	5660
2024 Q3	$2.82M	Buy	44,400 +20,600	+87%	+$1.49M	﹤0.01%	4901
2024 Q2	$1.61M	Buy	23,800 +15,300	+180%	+$1.07M	﹤0.01%	5725
2024 Q1	$673K	Sell	8,500 -9,600	-53%	-$785K	﹤0.01%	7744
2023 Q4	$1.41M	Sell	18,100 -2,800	-13%	-$207K	﹤0.01%	6014
2023 Q3	$1.47M	Sell	20,900 -4,600	-18%	-$344K	﹤0.01%	5809
2023 Q2	$2.03M	Buy	25,500 +16,400	+180%	+$1.19M	﹤0.01%	5129
2023 Q1	$657K	Sell	9,100 -1,000	-10%	-$77.9K	﹤0.01%	7727
2022 Q4	$831K	Buy	10,100 +5,200	+106%	+$429K	﹤0.01%	7167
2022 Q3	$383K	Sell	4,900 -100	-2%	-$7.99K	﹤0.01%	9038
2022 Q2	$338K	Sell	5,000 -11,300	-69%	-$788K	﹤0.01%	9545
2022 Q1	$1.07M	Sell	16,300 -11,400	-41%	-$662K	﹤0.01%	7539
2021 Q4	$1.68M	Sell	27,700 -11,300	-29%	-$674K	﹤0.01%	6641
2021 Q3	$2.49M	Buy	39,000 +20,300	+109%	+$1.28M	﹤0.01%	5819
2021 Q2	$1.17M	Sell	18,700 -23,100	-55%	-$1.45M	﹤0.01%	7936
2021 Q1	$2.39M	Sell	41,800 -12,800	-23%	-$693K	﹤0.01%	5979
2020 Q4	$2.74M	Buy	54,600 +41,200	+307%	+$1.64M	﹤0.01%	4729
2020 Q3	$395K	Sell	13,400 -50,300	-79%	-$1.46M	﹤0.01%	7689
2020 Q2	$1.6M	Buy	+63,700	New	+$1.59M	﹤0.01%	4960
2020 Q1	–	Sell	-14,000	Closed	-$465K	–	9521
2019 Q4	$465K	Sell	14,000 -31,600	-69%	-$990K	﹤0.01%	6933
2019 Q3	$1.42M	Sell	45,600 -75,500	-62%	-$2.3M	﹤0.01%	5024
2019 Q2	$4.23M	Buy	121,100 +83,300	+220%	+$2.69M	﹤0.01%	3343
2019 Q1	$1.11M	Sell	37,800 -107,100	-74%	-$3.03M	﹤0.01%	5402
2018 Q4	$3.73M	Buy	144,900 +130,900	+935%	+$4.53M	﹤0.01%	3219
2018 Q3	$493K	Buy	14,000 +6,400	+84%	+$255K	﹤0.01%	6727
2018 Q2	$311K	Sell	7,600 -5,600	-42%	-$226K	﹤0.01%	7151
2018 Q1	$517K	Buy	13,200 +4,100	+45%	+$150K	﹤0.01%	5828
2017 Q4	$297K	Sell	9,100 -4,800	-35%	-$166K	﹤0.01%	6478
2017 Q3	$664K	Buy	13,900 +1,800	+15%	+$87.7K	﹤0.01%	4912
2017 Q2	$597K	Sell	12,100 -700	-5%	-$31K	﹤0.01%	4873
2017 Q1	$558K	Buy	12,800 +900	+8%	+$36.5K	﹤0.01%	4827
2016 Q4	$394K	Sell	11,900 -10,900	-48%	-$423K	﹤0.01%	5273
2016 Q3	$1.13M	Buy	22,800 +13,400	+143%	+$698K	﹤0.01%	3682
2016 Q2	$521K	Sell	9,400 -9,900	-51%	-$579K	﹤0.01%	4426
2016 Q1	$1.06M	Buy	19,300 +13,700	+245%	+$782K	﹤0.01%	3400
2015 Q4	$350K	Sell	5,600 -5,200	-48%	-$339K	﹤0.01%	4992
2015 Q3	$716K	Buy	10,800 +2,100	+24%	+$162K	﹤0.01%	4271
2015 Q2	$681K	Buy	8,700 +1,400	+19%	+$101K	﹤0.01%	4510
2015 Q1	$523K	Sell	7,300 -1,800	-20%	-$115K	﹤0.01%	4838
2014 Q4	$557K	Buy	9,100 +4,300	+90%	+$250K	﹤0.01%	4581
2014 Q3	$233K	Sell	4,800 -1,700	-26%	-$83.1K	﹤0.01%	5561
2014 Q2	$296K	Buy	+6,500	New	+$286K	﹤0.01%	5082

Other funds holding ACHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors's ACHC Position: Q1 2026 in Review

Citadel Advisors increased its Acadia Healthcare (ACHC) stake by 100% in Q1 2026, buying an estimated $24.6M and bringing the position to 2,716,425 shares worth $63.5M. The position accounts for 0.01% of the portfolio, ranked #1145.

Citadel Advisors first reported a position in ACHC in Q3 2013 and has held it in 49 quarters since. The position peaked at $161M in Q2 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

Citadel Advisors held 2,716,425 shares of Acadia Healthcare worth $63.5M as of Q1 2026.
Citadel Advisors bought 1,361,142 Acadia Healthcare shares in Q1 2026, an estimated $24.6M.
Acadia Healthcare made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1145 holding.
Citadel Advisors first reported a position in Acadia Healthcare in Q3 2013 and has held it in 49 quarters since.
Citadel Advisors's Acadia Healthcare position peaked at $161M in Q2 2024.
295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.